Antiviral/immunomodulatory combination therapy: Pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection

Antiviral/immunomodulatory combination therapy: Pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection

Introduction. Chronic hepatitis C virus (HCV) infection can progress to liver cirrhosis that causes bleeding from the gastrointestinal tract, liver failure and primary hepatocellular carcinoma. Use of standard therapeutic option consists of recombinant pegylated interferon alpha 2a/b with ribavir...

Full description

Bibliographic Details
Main Authors: Delić Dragan, Mitrović Nikola, Popović Nataša, Urošević Aleksandar, Pešić Ivana, Simonović Jasmina, Dulović Olga, Švirtlih Neda
Format: Article
Language:English
Published: Serbian Medical Society 2012-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
hepatitis C virus
chronic hepatitis C
pegylated interferon alpha-2-a
ribavirin
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2012/0370-81791210612D.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0370-8179/2012/0370-81791210612D.pdf

Similar Items